
Pharmaceutical Recruitment: 2017 Trends and 2018 Outlook
By second quarter 2017 fears of what the new President would do to the health care industry had calmed down. No change in the ACA seemed to be imminent and the President had backed off
By second quarter 2017 fears of what the new President would do to the health care industry had calmed down. No change in the ACA seemed to be imminent and the President had backed off
Caution characterizes the pharmaceutical Industry at the start of 2017. What is our new President going to do? Is he pro pharmaceutical business or con? Even with this wait-and-see approach we expect strong pockets of